array:23 [
  "pii" => "S0001731012700054"
  "issn" => "00017310"
  "doi" => "10.1016/S0001-7310(12)70005-4"
  "estado" => "S300"
  "fechaPublicacion" => "2012-10-01"
  "aid" => "70005"
  "copyright" => "Academia Española de Dermatología y Venereología"
  "copyrightAnyo" => "2012"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:25-30"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1163
    "formatos" => array:2 [
      "HTML" => 621
      "PDF" => 542
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0001731012700066"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(12)70006-6"
    "estado" => "S300"
    "fechaPublicacion" => "2012-10-01"
    "aid" => "70006"
    "copyright" => "Academia Española de Dermatología y Venereología"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:31-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1299
      "formatos" => array:2 [
        "HTML" => 740
        "PDF" => 559
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Ustekinumab y seguridad cardiovascular"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "31"
          "paginaFinal" => "38"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Ustekinumab and Cardiovascular Safety"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J.C. Ruiz-Carrascosa"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "J.C."
              "apellidos" => "Ruiz-Carrascosa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700066?idApp=UINPBA000044"
    "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700066/v1_201304241722/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0001731012700042"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(12)70004-2"
    "estado" => "S300"
    "fechaPublicacion" => "2012-10-01"
    "aid" => "70004"
    "copyright" => "Academia Española de Dermatología y Venereología"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:16-24"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1703
      "formatos" => array:2 [
        "HTML" => 1283
        "PDF" => 420
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Eficacia de ustekinumab en el tratamiento de la psoriasis moderada-grave"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "16"
          "paginaFinal" => "24"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Efficacy of Ustekinumab in the Treatment of Moderate-Severe Psoriasis"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. Jiménez-Puya, J.C. Moreno"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "R."
              "apellidos" => "Jiménez-Puya"
            ]
            1 => array:2 [
              "nombre" => "J.C."
              "apellidos" => "Moreno"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700042?idApp=UINPBA000044"
    "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700042/v1_201304241722/es/main.assets"
  ]
  "es" => array:12 [
    "idiomaDefecto" => true
    "titulo" => "Ustekinumab. Análisis de efectos adversos infecciosos"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "25"
        "paginaFinal" => "30"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P. Herranz-Pinto, E. Sendagorta"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "P."
            "apellidos" => "Herranz-Pinto"
            "email" => array:1 [
              0 => "pherranzp@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "E&#46;"
            "apellidos" => "Sendagorta"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Dermatolog&#237;a&#46; Hospital Universitario La Paz&#46; Madrid&#46; Espa&#241;a"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Ustekinumab&#46; Analysis of Rates of Infection"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec85088"
          "palabras" => array:5 [
            0 => "Ustekinumab"
            1 => "Psoriasis"
            2 => "Efectos adversos"
            3 => "Seguridad"
            4 => "Infecciones"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec85089"
          "palabras" => array:5 [
            0 => "Ustekinumab"
            1 => "Psoriasis"
            2 => "Adverse effects"
            3 => "Safety"
            4 => "Infections"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Ustekinumab es el primer representante de un nuevo grupo de f&#225;rmacos biol&#243;gicos&#44; cuyo mecanismo de acci&#243;n principal es la inhibici&#243;n selectiva de la actividad de las interleucinas 12 y 23&#46; A pesar de ser la terapia de uso m&#225;s reciente en dermatolog&#237;a&#44; es el f&#225;rmaco que mayor n&#250;mero de pacientes ha aportado en su desarrollo cl&#237;nico en psoriasis&#46; Gracias a esta experiencia acumulada&#44; se ha confirmado que el perfil de seguridad de ustekinumab frente a eventos infecciosos demuestra un riesgo similar a placebo y equiparable a la poblaci&#243;n general en cuanto a incidencia absoluta&#44; infecciones severas y requerimientos de antibioterapia adicional&#46; Este comportamiento inicial se confirma durante el seguimiento a 3 y 4 a&#241;os en pacientes con psoriasis moderada a severa&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A pesar de este perfil favorable de seguridad&#44; el car&#225;cter inmunosupresor selectivo de ustekinumab aconseja mantener un seguimiento estricto de los pacientes en tratamiento&#44; como el despistaje de infecciones activas o latentes&#44; similar a los aplicados en el caso de los f&#225;rmacos anti factor de necrosis tumoral&#46;</p>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Ustekinumab is the first of a new class of biologic agents whose main mechanism of action involves the selective inhibition of IL-12 and IL-23&#46; Although ustekinumab is the latest biologic to be approved for use in dermatology&#44; its approval was based on the largest clinical development program conducted to date in psoriasis&#46; Safety data accumulated during the clinical development phase showed the risk of infection to be similar in patients in the ustekinumab and placebo groups&#46; The use of additional antibiotics and the rates of overall infection and serious infection in patients on ustekinumab and the general population were also comparable&#46; Subsequent studies confirmed the safety of this drug in patients with moderate to severe psoriasis treated for 3 or 4 years&#46; Despite its favorable safety profile&#44; ustekinumab is a selective immunosuppressant&#46; Clinicians should therefore closely monitor patients and apply screening measures similar to those used during anti-TNF therapy to detect de novo infections or the reactivation of latent infections&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "F&#46;O&#46; Nestle"
                            1 => "D&#46;H&#46; Kaplan"
                            2 => "J&#46; Barker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra0804595"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2009"
                        "volumen" => "361"
                        "paginaInicial" => "496"
                        "paginaFinal" => "509"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19641206"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New developments in the treatment of psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Lebwohl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol&#46;"
                        "fecha" => "2002"
                        "volumen" => "138"
                        "paginaInicial" => "686"
                        "paginaFinal" => "688"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12020234"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The IL-23&#47;Th17 axis in the immunopathogenesis of psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Di Cesare"
                            1 => "P&#46; Di Meglio"
                            2 => "F&#46;O&#46; Nestle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/jid.2009.59"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "2009"
                        "volumen" => "129"
                        "paginaInicial" => "1339"
                        "paginaFinal" => "1350"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19322214"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ustekinumab&#44; a human interleukin-12&#47;23 monoclonal antibody&#44; in patients with psoriasis&#58; 76-week results from a randomized&#44; double-blind&#44; placebo-controlled trial &#40;PHOENIX 1&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PHOENIX 1 study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;L&#46; Leonardi"
                            1 => "A&#46;B&#46; Kimball"
                            2 => "K&#46;A&#46; Papp"
                            3 => "N&#46; Yeilding"
                            4 => "C&#46; Guzzo"
                            5 => "Y&#46; Wang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(08)60725-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2008"
                        "volumen" => "371"
                        "paginaInicial" => "1665"
                        "paginaFinal" => "1674"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ustekinumab&#44; a human interleukin-12&#47;23 monoclonal antibody&#44; in patients with psoriasis&#58; 52-week results from a randomized&#44; double-blind&#44; placebo-controlled trial &#40;PHOENIX 2&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PHOENIX 2 study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;A&#46; Papp"
                            1 => "R&#46;G&#46; Langley"
                            2 => "M&#46; Lebwohl"
                            3 => "G&#46;G&#46; Krueger"
                            4 => "P&#46; Szapary"
                            5 => "N&#46; Yeilding"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(08)60726-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2008"
                        "volumen" => "371"
                        "paginaInicial" => "1675"
                        "paginaFinal" => "1684"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486740"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ustekinumab&#58; treatment of adult moderate-to-severe chronic plaque psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;V&#46; Scanlon"
                            1 => "B&#46;P&#46; Exter"
                            2 => "M&#46; Steinberg"
                            3 => "C&#46;I&#46; Jarvis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1M151"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother"
                        "fecha" => "2009"
                        "volumen" => "43"
                        "paginaInicial" => "1456"
                        "paginaFinal" => "1465"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19671802"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Leonardi C GL&#44; Wasel N&#44; Yeilding N&#44; Szapary P&#44; Hsu MC&#44; Langley R&#44; et al&#46; Characterization of infections associated with ustekinumab in moderate to severe psoriasis patients&#46; PO49&#46; Psoriasis 2010&#44; Congress of the International Psoriasis Network&#46; Paris&#44; 1&#8211;4 Jul 2010&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Gordon K LC&#44; Griffiths CEM&#44; Szapary P&#44; Yeilding N&#44; Hsu MC&#44; Wasel N&#44; et al&#46; Ustekinumab safety update&#58; cumulative experience from longer term follow-up of patients treated in the ustekinumab psoriasis clinical development program&#46; Psoriasis 2010&#44; Congress of the International Psoriasis Network&#46; Par&#237;s&#44; 1&#8211;4 Jul 2010&#46; Poster 047&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Reich K LC&#44; Griffiths CEM&#44; Szapary PO&#44; Wasfi Y&#44; Hsu MC&#44; Gordon K on behalf of the PHOENIX 1 &#38; 2 and ACCEPT investigators&#46; Update on the cumulative safety experience of ustekinumab&#58; results from the ustekinumab psoriasis clinical development program with up to 4 years of follow-up&#46; FC07-03 World Congress of Dermatology&#46; Se&#250;l&#44; Corea&#44; 2011&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The IL-12 family of heterodimeric cytokines&#58; new players in the regulation of T cell responses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G&#46; Trinchieri"
                            1 => "S&#46; Pflanz"
                            2 => "R&#46;A&#46; Kastelein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Immunity"
                        "fecha" => "2003"
                        "volumen" => "19"
                        "paginaInicial" => "641"
                        "paginaFinal" => "644"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14614851"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inborn errors of IL-12&#47;23- and IFN-gamma-mediated immunity&#58; molecular&#44; cellular&#44; and clinical features"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Filipe-Santos"
                            1 => "J&#46; Bustamante"
                            2 => "A&#46; Chapgier"
                            3 => "G&#46; Vogt"
                            4 => "L&#46; De Beaucoudrey"
                            5 => "J&#46; Feinberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.smim.2006.07.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Immunol"
                        "fecha" => "2006"
                        "volumen" => "18"
                        "paginaInicial" => "347"
                        "paginaFinal" => "361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16997570"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genetic dissection of immunity to mycobacteria&#58; the human model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46;L&#46; Casanova"
                            1 => "L&#46; Abel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1146/annurev.immunol.20.081501.125851"
                      "Revista" => array:6 [
                        "tituloSerie" => "Annu Rev Immunol"
                        "fecha" => "2002"
                        "volumen" => "20"
                        "paginaInicial" => "581"
                        "paginaFinal" => "620"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11861613"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The role of interleukin-12 in human infectious diseases&#58; only a faint signature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Fieschi"
                            1 => "J&#46;L&#46; Casanova"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/eji.200324038"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Immunol"
                        "fecha" => "2003"
                        "volumen" => "33"
                        "paginaInicial" => "1461"
                        "paginaFinal" => "1464"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12778462"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interleukin &#40;IL&#41;-12 and IL-23 are key cytokines for immunity against Salmonella in humans"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; MacLennan"
                            1 => "C&#46; Fieschi"
                            2 => "D&#46;A&#46; Lammas"
                            3 => "C&#46; Picard"
                            4 => "S&#46;E&#46; Dorman"
                            5 => "O&#46; Sanal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1086/425021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Infect Dis"
                        "fecha" => "2004"
                        "volumen" => "190"
                        "paginaInicial" => "1755"
                        "paginaFinal" => "1757"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15499529"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Revisiting human IL-12R&#946;1 deficiency&#58; a survey of 141 patients from 30 countries"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; De Beaucoudrey"
                            1 => "A&#46; Samarina"
                            2 => "J&#46; Bustamante"
                            3 => "A&#46; Cobat"
                            4 => "S&#46; Boisson- Dupuis"
                            5 => "J&#46; Feinberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Medicine &#40;Baltimore&#41;"
                        "fecha" => "2010"
                        "volumen" => "89"
                        "paginaInicial" => "381"
                        "paginaFinal" => "402"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib16"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Herranz-Pinto P S-CE&#44; Casado-Verrier B&#44; G&#243;mez-Fern&#225;ndez C&#44; Alonso-Pacheco ML&#44; Casado-Jim&#233;nez ML&#46; Psoriasis en pacientes con coinfecci&#243;n VIH-VHC&#46; Primer a&#241;o de tratamiento con ustekinumab&#46; P&#243;ster Congreso Nacional de Dermatolog&#237;a 2011&#46; Santiago de Compostela&#44; 2011&#46;"
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700054/v1_201304241722/es/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/00017310/00000103000000S2/v1_201304241722/S0001731012700054/v1_201304241722/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700054?idApp=UINPBA000044"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Ustekinumab. Análisis de efectos adversos infecciosos
Ustekinumab. Analysis of Rates of Infection
P. Herranz-Pinto
Autor para correspondencia
pherranzp@gmail.com

Autor para correspondencia.
, E. Sendagorta
Servicio de Dermatología. Hospital Universitario La Paz. Madrid. España
Leído
4292
Veces
se ha leído el artículo
2231
Total PDF
2061
Total HTML
Compartir estadísticas
 array:23 [
  "pii" => "S0001731012700054"
  "issn" => "00017310"
  "doi" => "10.1016/S0001-7310(12)70005-4"
  "estado" => "S300"
  "fechaPublicacion" => "2012-10-01"
  "aid" => "70005"
  "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
  "copyrightAnyo" => "2012"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:25-30"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1163
    "formatos" => array:2 [
      "HTML" => 621
      "PDF" => 542
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0001731012700066"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(12)70006-6"
    "estado" => "S300"
    "fechaPublicacion" => "2012-10-01"
    "aid" => "70006"
    "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:31-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1299
      "formatos" => array:2 [
        "HTML" => 740
        "PDF" => 559
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Ustekinumab y seguridad cardiovascular"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "31"
          "paginaFinal" => "38"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Ustekinumab and Cardiovascular Safety"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;C&#46; Ruiz-Carrascosa"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Ruiz-Carrascosa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700066?idApp=UINPBA000044"
    "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700066/v1_201304241722/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0001731012700042"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(12)70004-2"
    "estado" => "S300"
    "fechaPublicacion" => "2012-10-01"
    "aid" => "70004"
    "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:16-24"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1703
      "formatos" => array:2 [
        "HTML" => 1283
        "PDF" => 420
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Eficacia de ustekinumab en el tratamiento de la psoriasis moderada-grave"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "16"
          "paginaFinal" => "24"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Efficacy of Ustekinumab in the Treatment of Moderate-Severe Psoriasis"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R&#46; Jim&#233;nez-Puya, J&#46;C&#46; Moreno"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Jim&#233;nez-Puya"
            ]
            1 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Moreno"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700042?idApp=UINPBA000044"
    "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700042/v1_201304241722/es/main.assets"
  ]
  "es" => array:12 [
    "idiomaDefecto" => true
    "titulo" => "Ustekinumab&#46; An&#225;lisis de efectos adversos infecciosos"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "25"
        "paginaFinal" => "30"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P&#46; Herranz-Pinto, E&#46; Sendagorta"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "P&#46;"
            "apellidos" => "Herranz-Pinto"
            "email" => array:1 [
              0 => "pherranzp&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "E&#46;"
            "apellidos" => "Sendagorta"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Dermatolog&#237;a&#46; Hospital Universitario La Paz&#46; Madrid&#46; Espa&#241;a"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Ustekinumab&#46; Analysis of Rates of Infection"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec85088"
          "palabras" => array:5 [
            0 => "Ustekinumab"
            1 => "Psoriasis"
            2 => "Efectos adversos"
            3 => "Seguridad"
            4 => "Infecciones"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec85089"
          "palabras" => array:5 [
            0 => "Ustekinumab"
            1 => "Psoriasis"
            2 => "Adverse effects"
            3 => "Safety"
            4 => "Infections"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Ustekinumab es el primer representante de un nuevo grupo de f&#225;rmacos biol&#243;gicos&#44; cuyo mecanismo de acci&#243;n principal es la inhibici&#243;n selectiva de la actividad de las interleucinas 12 y 23&#46; A pesar de ser la terapia de uso m&#225;s reciente en dermatolog&#237;a&#44; es el f&#225;rmaco que mayor n&#250;mero de pacientes ha aportado en su desarrollo cl&#237;nico en psoriasis&#46; Gracias a esta experiencia acumulada&#44; se ha confirmado que el perfil de seguridad de ustekinumab frente a eventos infecciosos demuestra un riesgo similar a placebo y equiparable a la poblaci&#243;n general en cuanto a incidencia absoluta&#44; infecciones severas y requerimientos de antibioterapia adicional&#46; Este comportamiento inicial se confirma durante el seguimiento a 3 y 4 a&#241;os en pacientes con psoriasis moderada a severa&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A pesar de este perfil favorable de seguridad&#44; el car&#225;cter inmunosupresor selectivo de ustekinumab aconseja mantener un seguimiento estricto de los pacientes en tratamiento&#44; como el despistaje de infecciones activas o latentes&#44; similar a los aplicados en el caso de los f&#225;rmacos anti factor de necrosis tumoral&#46;</p>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Ustekinumab is the first of a new class of biologic agents whose main mechanism of action involves the selective inhibition of IL-12 and IL-23&#46; Although ustekinumab is the latest biologic to be approved for use in dermatology&#44; its approval was based on the largest clinical development program conducted to date in psoriasis&#46; Safety data accumulated during the clinical development phase showed the risk of infection to be similar in patients in the ustekinumab and placebo groups&#46; The use of additional antibiotics and the rates of overall infection and serious infection in patients on ustekinumab and the general population were also comparable&#46; Subsequent studies confirmed the safety of this drug in patients with moderate to severe psoriasis treated for 3 or 4 years&#46; Despite its favorable safety profile&#44; ustekinumab is a selective immunosuppressant&#46; Clinicians should therefore closely monitor patients and apply screening measures similar to those used during anti-TNF therapy to detect de novo infections or the reactivation of latent infections&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "F&#46;O&#46; Nestle"
                            1 => "D&#46;H&#46; Kaplan"
                            2 => "J&#46; Barker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra0804595"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2009"
                        "volumen" => "361"
                        "paginaInicial" => "496"
                        "paginaFinal" => "509"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19641206"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New developments in the treatment of psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Lebwohl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol&#46;"
                        "fecha" => "2002"
                        "volumen" => "138"
                        "paginaInicial" => "686"
                        "paginaFinal" => "688"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12020234"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The IL-23&#47;Th17 axis in the immunopathogenesis of psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Di Cesare"
                            1 => "P&#46; Di Meglio"
                            2 => "F&#46;O&#46; Nestle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/jid.2009.59"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "2009"
                        "volumen" => "129"
                        "paginaInicial" => "1339"
                        "paginaFinal" => "1350"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19322214"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ustekinumab&#44; a human interleukin-12&#47;23 monoclonal antibody&#44; in patients with psoriasis&#58; 76-week results from a randomized&#44; double-blind&#44; placebo-controlled trial &#40;PHOENIX 1&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PHOENIX 1 study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;L&#46; Leonardi"
                            1 => "A&#46;B&#46; Kimball"
                            2 => "K&#46;A&#46; Papp"
                            3 => "N&#46; Yeilding"
                            4 => "C&#46; Guzzo"
                            5 => "Y&#46; Wang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(08)60725-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2008"
                        "volumen" => "371"
                        "paginaInicial" => "1665"
                        "paginaFinal" => "1674"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ustekinumab&#44; a human interleukin-12&#47;23 monoclonal antibody&#44; in patients with psoriasis&#58; 52-week results from a randomized&#44; double-blind&#44; placebo-controlled trial &#40;PHOENIX 2&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PHOENIX 2 study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;A&#46; Papp"
                            1 => "R&#46;G&#46; Langley"
                            2 => "M&#46; Lebwohl"
                            3 => "G&#46;G&#46; Krueger"
                            4 => "P&#46; Szapary"
                            5 => "N&#46; Yeilding"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(08)60726-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2008"
                        "volumen" => "371"
                        "paginaInicial" => "1675"
                        "paginaFinal" => "1684"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486740"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ustekinumab&#58; treatment of adult moderate-to-severe chronic plaque psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;V&#46; Scanlon"
                            1 => "B&#46;P&#46; Exter"
                            2 => "M&#46; Steinberg"
                            3 => "C&#46;I&#46; Jarvis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1M151"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother"
                        "fecha" => "2009"
                        "volumen" => "43"
                        "paginaInicial" => "1456"
                        "paginaFinal" => "1465"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19671802"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Leonardi C GL&#44; Wasel N&#44; Yeilding N&#44; Szapary P&#44; Hsu MC&#44; Langley R&#44; et al&#46; Characterization of infections associated with ustekinumab in moderate to severe psoriasis patients&#46; PO49&#46; Psoriasis 2010&#44; Congress of the International Psoriasis Network&#46; Paris&#44; 1&#8211;4 Jul 2010&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Gordon K LC&#44; Griffiths CEM&#44; Szapary P&#44; Yeilding N&#44; Hsu MC&#44; Wasel N&#44; et al&#46; Ustekinumab safety update&#58; cumulative experience from longer term follow-up of patients treated in the ustekinumab psoriasis clinical development program&#46; Psoriasis 2010&#44; Congress of the International Psoriasis Network&#46; Par&#237;s&#44; 1&#8211;4 Jul 2010&#46; Poster 047&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Reich K LC&#44; Griffiths CEM&#44; Szapary PO&#44; Wasfi Y&#44; Hsu MC&#44; Gordon K on behalf of the PHOENIX 1 &#38; 2 and ACCEPT investigators&#46; Update on the cumulative safety experience of ustekinumab&#58; results from the ustekinumab psoriasis clinical development program with up to 4 years of follow-up&#46; FC07-03 World Congress of Dermatology&#46; Se&#250;l&#44; Corea&#44; 2011&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The IL-12 family of heterodimeric cytokines&#58; new players in the regulation of T cell responses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G&#46; Trinchieri"
                            1 => "S&#46; Pflanz"
                            2 => "R&#46;A&#46; Kastelein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Immunity"
                        "fecha" => "2003"
                        "volumen" => "19"
                        "paginaInicial" => "641"
                        "paginaFinal" => "644"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14614851"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inborn errors of IL-12&#47;23- and IFN-gamma-mediated immunity&#58; molecular&#44; cellular&#44; and clinical features"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Filipe-Santos"
                            1 => "J&#46; Bustamante"
                            2 => "A&#46; Chapgier"
                            3 => "G&#46; Vogt"
                            4 => "L&#46; De Beaucoudrey"
                            5 => "J&#46; Feinberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.smim.2006.07.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Immunol"
                        "fecha" => "2006"
                        "volumen" => "18"
                        "paginaInicial" => "347"
                        "paginaFinal" => "361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16997570"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genetic dissection of immunity to mycobacteria&#58; the human model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46;L&#46; Casanova"
                            1 => "L&#46; Abel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1146/annurev.immunol.20.081501.125851"
                      "Revista" => array:6 [
                        "tituloSerie" => "Annu Rev Immunol"
                        "fecha" => "2002"
                        "volumen" => "20"
                        "paginaInicial" => "581"
                        "paginaFinal" => "620"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11861613"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The role of interleukin-12 in human infectious diseases&#58; only a faint signature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Fieschi"
                            1 => "J&#46;L&#46; Casanova"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/eji.200324038"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Immunol"
                        "fecha" => "2003"
                        "volumen" => "33"
                        "paginaInicial" => "1461"
                        "paginaFinal" => "1464"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12778462"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interleukin &#40;IL&#41;-12 and IL-23 are key cytokines for immunity against Salmonella in humans"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; MacLennan"
                            1 => "C&#46; Fieschi"
                            2 => "D&#46;A&#46; Lammas"
                            3 => "C&#46; Picard"
                            4 => "S&#46;E&#46; Dorman"
                            5 => "O&#46; Sanal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1086/425021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Infect Dis"
                        "fecha" => "2004"
                        "volumen" => "190"
                        "paginaInicial" => "1755"
                        "paginaFinal" => "1757"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15499529"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Revisiting human IL-12R&#946;1 deficiency&#58; a survey of 141 patients from 30 countries"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; De Beaucoudrey"
                            1 => "A&#46; Samarina"
                            2 => "J&#46; Bustamante"
                            3 => "A&#46; Cobat"
                            4 => "S&#46; Boisson- Dupuis"
                            5 => "J&#46; Feinberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Medicine &#40;Baltimore&#41;"
                        "fecha" => "2010"
                        "volumen" => "89"
                        "paginaInicial" => "381"
                        "paginaFinal" => "402"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib16"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Herranz-Pinto P S-CE&#44; Casado-Verrier B&#44; G&#243;mez-Fern&#225;ndez C&#44; Alonso-Pacheco ML&#44; Casado-Jim&#233;nez ML&#46; Psoriasis en pacientes con coinfecci&#243;n VIH-VHC&#46; Primer a&#241;o de tratamiento con ustekinumab&#46; P&#243;ster Congreso Nacional de Dermatolog&#237;a 2011&#46; Santiago de Compostela&#44; 2011&#46;"
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700054/v1_201304241722/es/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/00017310/00000103000000S2/v1_201304241722/S0001731012700054/v1_201304241722/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700054?idApp=UINPBA000044"
]
Información del artículo
ISSN: 00017310
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 5 10 15
2024 Octubre 31 37 68
2024 Septiembre 29 22 51
2024 Agosto 49 44 93
2024 Julio 41 27 68
2024 Junio 55 28 83
2024 Mayo 47 45 92
2024 Abril 44 31 75
2024 Marzo 29 30 59
2024 Febrero 23 27 50
2024 Enero 18 25 43
2023 Diciembre 22 17 39
2023 Noviembre 26 21 47
2023 Octubre 24 18 42
2023 Septiembre 22 27 49
2023 Agosto 26 22 48
2023 Julio 21 26 47
2023 Junio 12 33 45
2023 Mayo 9 22 31
2023 Abril 17 25 42
2023 Marzo 15 33 48
2023 Febrero 17 22 39
2023 Enero 17 31 48
2022 Diciembre 22 39 61
2022 Noviembre 23 34 57
2022 Octubre 69 26 95
2022 Septiembre 49 40 89
2022 Agosto 44 45 89
2022 Julio 22 45 67
2022 Junio 15 55 70
2022 Mayo 22 38 60
2022 Abril 31 30 61
2022 Marzo 20 42 62
2022 Febrero 20 26 46
2022 Enero 21 36 57
2021 Diciembre 15 32 47
2021 Noviembre 22 41 63
2021 Octubre 21 51 72
2021 Septiembre 20 44 64
2021 Agosto 25 28 53
2021 Julio 11 24 35
2021 Junio 19 49 68
2021 Mayo 18 40 58
2021 Abril 49 63 112
2021 Marzo 42 39 81
2021 Febrero 26 24 50
2021 Enero 25 13 38
2020 Diciembre 15 17 32
2020 Noviembre 10 17 27
2020 Octubre 24 12 36
2020 Septiembre 11 6 17
2020 Agosto 21 13 34
2020 Julio 19 11 30
2020 Junio 24 22 46
2020 Mayo 21 32 53
2020 Abril 20 15 35
2020 Marzo 25 17 42
2020 Enero 0 5 5
2019 Diciembre 0 3 3
2019 Noviembre 0 1 1
2019 Octubre 0 2 2
2019 Septiembre 0 5 5
2019 Agosto 0 1 1
2019 Julio 0 6 6
2019 Junio 0 3 3
2019 Mayo 0 23 23
2019 Abril 0 25 25
2019 Febrero 1 5 6
2019 Enero 0 3 3
2018 Diciembre 1 7 8
2018 Noviembre 0 2 2
2018 Octubre 0 3 3
2018 Agosto 0 6 6
2018 Junio 0 4 4
2018 Febrero 13 5 18
2018 Enero 12 4 16
2017 Diciembre 12 9 21
2017 Noviembre 10 7 17
2017 Octubre 8 5 13
2017 Septiembre 9 7 16
2017 Agosto 6 10 16
2017 Julio 12 3 15
2017 Junio 14 6 20
2017 Mayo 8 9 17
2017 Abril 18 16 34
2017 Marzo 11 25 36
2017 Febrero 9 9 18
2017 Enero 10 21 31
2016 Diciembre 23 11 34
2016 Noviembre 23 12 35
2016 Octubre 22 9 31
2016 Septiembre 30 13 43
2016 Agosto 29 15 44
2016 Julio 18 8 26
2016 Junio 0 4 4
2016 Mayo 0 9 9
2016 Abril 1 1 2
2016 Marzo 0 2 2
2016 Febrero 0 4 4
2016 Enero 0 16 16
2015 Diciembre 0 19 19
2015 Noviembre 5 16 21
2015 Octubre 3 5 8
2015 Septiembre 5 13 18
2015 Agosto 6 7 13
2015 Julio 22 3 25
2015 Junio 21 3 24
2015 Mayo 45 19 64
2015 Abril 30 12 42
2015 Marzo 26 20 46
2015 Febrero 29 10 39
2015 Enero 33 12 45
2014 Diciembre 34 8 42
2014 Noviembre 23 11 34
2014 Octubre 34 29 63
2014 Septiembre 0 2 2
2014 Mayo 1 0 1
2014 Enero 0 1 1
2013 Septiembre 1 1 2
2013 Junio 0 1 1
2013 Mayo 1 1 2
2013 Abril 1 2 3
2013 Febrero 1 2 3
2013 Enero 0 1 1
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?